CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

CD24 has been described as an adverse prognostic marker in several malignancies. This study evaluates CD24 expression in cholangiocarcinoma and correlates the findings with clinicopathologic data and patient survival. Between 1996 and 2002, 22 consecutive patients with cholangiocarcinoma were treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Shefali, Kuvshinoff, Boris W., Khoury, Thaer, Yu, Jihnhee, Javle, Milind M., LeVea, Charles, Groth, Jeff, Coignet, Lionel J., Gibbs, John F.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852393/
https://www.ncbi.nlm.nih.gov/pubmed/17436128
http://dx.doi.org/10.1007/s11605-007-0091-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852393/
https://www.ncbi.nlm.nih.gov/pubmed/17436128
http://dx.doi.org/10.1007/s11605-007-0091-5

Ejemplares similares